Roche (OTCQX: RHHBY) Moves to Acquire PathAI for AI-Driven Diagnostics
Market Overview Roche (OTCQX: RHHBY), a global leader in healthcare, has taken a significant step forward in the field of AI-driven diagnostics with the announcement of a definitive agreement to acquire PathAI. This move comes after several years of successful collaboration between the two companies, signaling Roche’s commitment to advancing digital pathology and AI-based solutions. The acquisition is expected to enhance Roche’s Diagnostics division and fortify its position in innovative…









